Analyzing HPV Vaccination Service Preferences among Female University Students in China: A Discrete Choice Experiment

Author:

Hu Lu1,Jiang Jiacheng1,Chen Zhu1ORCID,Chen Sixuan1,Jin Xinyu1,Gao Yingman1,Wang Li12,Wang Lidan12

Affiliation:

1. School of Health Management, Anhui Medical University, Hefei 230032, China

2. Centre for Health Policy Research, Anhui Medical University, Hefei 230032, China

Abstract

Objective: Despite being primary beneficiaries of human papillomavirus (HPV) vaccines, female university students in China exhibit low vaccination rates. This study aimed to assess their preferences for HPV vaccination services and evaluate the relative importance of various factors to inform vaccination strategy development. Methods: Through a literature review and expert consultations, we identified five key attributes for study: effectiveness, protection duration, waiting time, distance, and out-of-pocket (OOP) payment. A D-efficient design was used to create a discrete choice experiment (DCE) questionnaire. We collected data via face-to-face interviews and online surveys from female students across seven universities in China, employing mixed logit and latent class logit models to analyze the data. The predicted uptake and compensating variation (CV) were used to compare different vaccination service scenarios. Results: From 1178 valid questionnaires, with an effective response rate of 92.9%, we found that effectiveness was the most significant factor influencing vaccination preference, followed by protection duration, OOP payment and waiting time, with less concern for distance. The preferred services included a 90% effective vaccine, lifetime protection, a waiting time of less than three months, a travel time of more than 60 min, and low OOP payment. Significant variability in preferences across different vaccination service scenarios was observed, affecting potential market shares. The CV analysis showed female students were willing to spend approximately CNY 5612.79 to include a hypothetical ‘Service 5’ (a vaccine with higher valency than the nine-valent HPV vaccine) in their prevention options. Conclusions: The findings underscore the need for personalized, need-based HPV vaccination services that cater specifically to the preferences of female university students to increase vaccination uptake and protect their health.

Funder

Anhui Zhongji Guoyi Medical Technology Co., Ltd.

2022 National Innovation and Entrepreneurship Training Project for University

Key Laboratory of Public Health Social Governance, Philosophy and Social Sciences of Anhui Province

Anhui Provincial Natural Science Foundation

Publisher

MDPI AG

Reference47 articles.

1. Human Papillomavirus and Cervical Cancer;Crosbie;Lancet,2013

2. (2023, March 14). Cervical Cancer. Available online: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer.

3. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021

4. Present Status of Human Papillomavirus Vaccine Development and Implementation;Herrero;Lancet Oncol.,2015

5. HPV Vaccines to Prevent Cervical Cancer and Genital Warts: An Update;Dochez;Vaccine,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3